The insufflation devices market has seen considerable growth due to a variety of factors.
• The market size of insufflation devices has exhibited considerable expansion in the preceding years. The growth is forecasted to progress from $2.74 billion in 2024 to reach $2.95 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 7.5%.
The notable growth during the historic timeframe has been driven by factors such as the upsurge in laparoscopic surgeries, growing interest for minimally invasive approaches, expansion of daycare surgery centers, increased efforts to curtail surgical complications, and a heightened demand for accurate surgical tools for treating cancer.
The insufflation devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of insufflation devices is projected to experience significant growth in the coming years, going up to $3.90 billion in 2029, with a 7.2% compound annual growth rate (CAGR). This rise during the forecast period is due to factors such as the growing demand for surgeries facilitated by robots, the escalating geriatric population, the surge in cosmetic and aesthetic operations, increasing awareness and educational programs, and the growing incidence of chronic ailments. During the forecast period, significant trends include the progression of endoscopic surgical procedures, the embracing of telemedicine, advancements in CO2 recycling and conservation strategies, progress in insufflation device technology, and the incorporation of artificial intelligence and machine learning.
The increasing prevalence of obesity is anticipated to stimulate the expansion of the insufflation devices market. The obesity rate represents the portion of the population that is considered obese, usually determined by a body mass index (BMI) of 30 or more. The key causes contributing to rising obesity rates include unhealthy eating habits, lack of physical exercise, high consumption of processed foods, and sedentary ways of living. Insufflation devices, employed in obesity treatments, facilitate procedures like bariatric surgery by inflating the abdominal cavity, improving visibility and access. For instance, in March 2023, the World Heart Foundation, a non-government global cardiovascular organization based in Switzerland, reported that currently around 2.3 billion adults and children worldwide are obese or overweight. Given the continuing obesity trend, the figure is expected to touch 2.7 billion by 2025. Consequently, the escalating rates of obesity are acting as a catalyst for the growth of the insufflation devices market.
The insufflation devices market covered in this report is segmented –
1) By Type: Disposable, Reusable
2) By Application: Laparoscopic Surgery, Bariatric Surgery, Cardiac Surgery
3) By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Disposable: Single-Use Insufflation Devices, Disposable Insufflation Tubes
2) By Reusable: Reusable Insufflation Devices (Manual Or Electronic), Reusable Insufflation Tubes
Leading firms in the insufflation devices sector are focusing on the invention of innovative products like smart turbine insufflators. These products aim to increase accuracy, lower surgical risks, and improve patient results in minimally invasive operations. Intelligent turbine insufflators provide a regulated, high-pressure airflow to assist in insufflation during less invasive surgeries and possess sophisticated features for precision and safety. In October 2024, Politecnico di Milano, a university based in Italy, collaborated with Erasmus Medical Center from the Netherlands to engineer insufflators that can advance surgical operations by producing a temporary cavity in the body using pressurized gas. This innovation surpasses the present insufflator's limitations as it constantly changes pressure according to the patient's tissue and breathing traits. This trademarked intelligent turbine insufflation technique enhances surgical conditions and patient outcomes by reducing the need for large cuts and providing more accuracy during surgery.
Major companies operating in the insufflation devices market are include:
• Cardinal Health Inc.
• Johnson & Johnson
• Medtronic plc
• Fujifilm Holdings Corporation
• Becton Dickinson and Company
• Stryker Corporation
• Olympus Corporation
• Hoya Corporation
• Smith & Nephew PLC
• Mindray Medical International Limited
• STERIS Corporation
• CooperSurgical Inc.
• Teleflex Incorporated
• Karl Storz SE & Co. KG
• ConMed Corporation
• Applied Medical Resources Corporation
• Richard Wolf GmbH
• B. Braun Melsungen AG
• Pennine Healthcare Limited
• Micro-Tech Endoscopy Co. Ltd.
North America is the largest region in the insufflation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insufflation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.